Studies showed that the reduction of EGR1 protein level can cooperate with anti‐oestrogen to inhibit the proliferation of breast cancer cells; and EGR1 is expected to be an important target to prevent or reverse endocrine resistance.104. The gene discussed is EGR1; the disease is breast carcinoma.